%0 Journal Article
%T Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses
%A Hillegass, William B.
%A Bradford, Gregory S.
%J Journal of Thoracic Disease
%D 2016
%B 2016
%9 
%! Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses
%K 
%X During percutaneous coronary intervention, dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist are combined with one of three major strategies for antithrombotic therapy: heparins, bivalirudin, or heparin with an intravenous IIb/IIIa platelet receptor antagonist. Economic constraints in the United States are increasingly driving the choice between these therapies.
%U https://jtd.amegroups.org/article/view/9305
%V 8
%N 9
%P E1034-E1040
%@ 2077-6624